$ Value
$89K
Shares
2,700
Price
$33
Filed
Dec 3
Insider
Name
Meyer Andrew Hollman
Title
Chief Business Officer
CIK
0001864159
Roles
Transaction Details
Transaction Date
2025-12-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
85,607
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024. | The weighted average sale price for the transaction reported was $32.8548 and the range of prices were between $32.27 and $33.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $33.5247 and the range of prices were between $33.28 and $33.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | Immediately exercisable.
Filing Info
Meyer Andrew Hollman's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | JANX | ▼ | $26K |
| 2025-12-01 | JANX | M | $35K |
| 2025-12-01 | JANX | ▼ | $89K |
| 2025-12-01 | JANX | ▼ | $21K |
| 2025-12-01 | JANX | M | $0 |
| 2025-11-14 | JANX | M | $35K |
| 2025-11-14 | JANX | ▼ | $100K |
| 2025-11-14 | JANX | M | $0 |
| 2025-10-28 | JANX | M | $42K |
| 2025-10-28 | JANX | M | $71K |
Other Insiders at JANX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Go William
Chief Medical Officer
|
— | — | 2026-02-02 |